title: The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells.
authors.forename: Valerie R
authors.initials: VR
authors.lastname: Wiersma
authors.forename: Marco
authors.initials: M
authors.lastname: de Bruyn
authors.forename: Robert J
authors.initials: RJ
authors.lastname: van Ginkel
authors.forename: Emily
authors.initials: E
authors.lastname: Sigar
authors.forename: Mitsuomi
authors.initials: M
authors.lastname: Hirashima
authors.forename: Toshiro
authors.initials: T
authors.lastname: Niki
authors.forename: Nozomu
authors.initials: N
authors.lastname: Nishi
authors.forename: Douwe F
authors.initials: DF
authors.lastname: Samplonius
authors.forename: Wijnand
authors.initials: W
authors.lastname: Helfrich
authors.forename: Edwin
authors.initials: E
authors.lastname: Bremer
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D037161:Galectins / Q000494:pharmacology*; D006801:Humans; D008544:Melanocytes / Q000187:drug effects; D008545:Melanoma / Q000378:metabolism*; D051379:Mice; D012878:Skin Neoplasms / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D037161:Galectins; C105032:LGALS9 protein, human